Progressive Care, Inc. (RXMD)
USD 2.11
(5.5%)
USD 2.11
(5.5%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 874 Thousand | 669.4 Thousand | -757.92 Thousand | 1.14 Million | -614.73 Thousand | -253.22 Thousand |
| Net Income | -19.41 Million | -6.44 Million | 217.99 Thousand | -1.44 Million | -2.5 Million | -1.62 Million |
| Depreciation & Amortization | 1.78 Million | 360.78 Thousand | 567.39 Thousand | 852.62 Thousand | 457.83 Thousand | 159.17 Thousand |
| Deferred income taxes | -7.31 Million | - | -2.77 Million | -793.8 Thousand | -43 Thousand | - |
| Stock-based compensation | 1.6 Million | 1.9 Million | 247.67 Thousand | 48.2 Thousand | 43 Thousand | 591.87 Thousand |
| Change in working capital | -7.21 Million | -507.39 Thousand | -333.89 Thousand | 1.81 Million | 253.54 Thousand | 535.11 Thousand |
| Other non-cash items | 24.12 Million | 5.35 Million | 1.31 Million | 675.89 Thousand | 1.17 Million | 682.24 Thousand |
| Investing Cash Flow | -769 Thousand | -184.32 Thousand | -123.31 Thousand | -669.61 Thousand | -2.24 Million | -572.4 Thousand |
| Investments in PPE | -772 Thousand | -195.88 Thousand | -123.31 Thousand | -669.61 Thousand | -36.02 Thousand | -142.22 Thousand |
| Acquisitions | 3000.00 | 11.56 Thousand | - | - | -2.2 Million | -430.17 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 3000.00 | 2000.00 | - | - | - | - |
| Financing Cash Flow | 1.04 Million | 4.84 Million | 192.65 Thousand | 804.4 Thousand | 3.58 Million | 493.14 Thousand |
| Debt repayment | -304 Thousand | -353 Thousand | -228.74 Thousand | -209.49 Thousand | -161.17 Thousand | -93.15 Thousand |
| Dividends payments | - | -541.27 Thousand | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.35 Million | 5.42 Million | - | - | - | - |
| Other Financing Activities | 1.35 Million | 5.19 Million | 421.4 Thousand | 1.01 Million | 3.75 Million | 586.3 Thousand |
| Accounts receivables | -4.85 Million | -1.46 Million | 269.71 Thousand | -596 Thousand | -992.75 Thousand | -93.25 Thousand |
| Accounts payables | 4.78 Million | 1.62 Million | 23.31 Thousand | 2.34 Million | 1.13 Million | 390.57 Thousand |
| Inventory | -2.35 Million | 437.1 Thousand | -205.11 Thousand | -223.13 Thousand | 209.84 Thousand | 200.7 Thousand |
| Other working capital | -6000.00 | -1.1 Million | -421.81 Thousand | 287.9 Thousand | -95.68 Thousand | 37.09 Thousand |
| Cash at beginning of period | 6.74 Million | 1.41 Million | 2.1 Million | 816.63 Thousand | 86.83 Thousand | 419.31 Thousand |
| Cash at end of period | 15.24 Million | 6.74 Million | 1.41 Million | 2.1 Million | 816.63 Thousand | 86.83 Thousand |
| Capital Expenditure | -772 Thousand | -195.88 Thousand | -123.31 Thousand | -669.61 Thousand | -36.02 Thousand | -142.22 Thousand |
| Effect of forex changes on cash | -873.99 Thousand | - | - | - | - | - |
| Net cash flow / Change in cash | 8.5 Million | 5.33 Million | -688.58 Thousand | 1.28 Million | 729.8 Thousand | -332.48 Thousand |
| Free Cash Flow | 102 Thousand | 473.52 Thousand | -881.24 Thousand | 479.65 Thousand | -650.76 Thousand | -395.45 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -9.27 Million | -372 Thousand | -19.41 Million | -13.27 Million | -1.37 Million | -4.63 Million |
| Depreciation & Amortization | 786 Thousand | 820 Thousand | 1.78 Million | 818.46 Thousand | 746.93 Thousand | 114.06 Thousand |
| Deferred income taxes | - | - | -7.31 Million | -2.28 Million | - | 9500.00 |
| Stock-based compensation | - | 65 Thousand | 1.6 Million | 151.16 Thousand | 1.2 Million | 189.6 Thousand |
| Change in working capital | 1.83 Million | -2.92 Million | -2.43 Million | -643.54 Thousand | -845.85 Thousand | -1.6 Million |
| Other non-cash items | 9.48 Million | 4.86 Million | 26.65 Million | 16.21 Million | 12 Thousand | 5.25 Million |
| Investing Cash Flow | -39 Thousand | -23 Thousand | -769 Thousand | -188.27 Thousand | -349.86 Thousand | -213.37 Thousand |
| Investments in PPE | -39 Thousand | -24 Thousand | -772 Thousand | -188.77 Thousand | -349.86 Thousand | -215.87 Thousand |
| Acquisitions | - | 1000.00 | 3000.00 | 500.00 | - | 2500.00 |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | 1000.00 | 3000.00 | 500.00 | -349.86 Thousand | 2500.00 |
| Financing Cash Flow | -53 Thousand | -51 Thousand | 1.04 Million | 84.56 Thousand | 272.47 Thousand | 790.64 Thousand |
| Debt repayment | -53 Thousand | -51 Thousand | -304 Thousand | -119.56 Thousand | -233.52 Thousand | -89.35 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 1.35 Million | -35 Thousand | 506 Thousand | 880 Thousand |
| Other Financing Activities | - | -46 Thousand | 1.35 Million | -35 Thousand | 272.47 Thousand | 790.64 Thousand |
| Accounts receivables | 3.97 Million | -4.13 Million | -4.57 Million | -28.35 Thousand | -3.72 Million | -721.78 Thousand |
| Accounts payables | -3.19 Million | 1.42 Million | 4.78 Million | -403.24 Thousand | 4.33 Million | -1.03 Million |
| Inventory | 1.04 Million | -316 Thousand | -2.35 Million | -64.2 Thousand | -1.37 Million | -367.38 Thousand |
| Other working capital | 16 Thousand | 108 Thousand | -283 Thousand | -147.75 Thousand | -79.26 Thousand | 515.36 Thousand |
| Cash at beginning of period | 5.54 Million | 7.89 Million | 6.74 Million | 7.01 Million | 7.35 Million | 7.45 Million |
| Cash at end of period | 8.53 Million | 5.54 Million | 7.89 Million | 7.89 Million | 7.01 Million | 7.35 Million |
| Capital Expenditure | -39 Thousand | -24 Thousand | -772 Thousand | -188.77 Thousand | -349.86 Thousand | -215.87 Thousand |
| Effect of forex changes on cash | - | - | -873.99 Thousand | 124.00 | 259.82 Thousand | - |
| Net cash flow / Change in cash | 2.99 Million | -2.35 Million | 1.15 Million | 880.02 Thousand | -337.21 Thousand | -99.58 Thousand |
| Free Cash Flow | 3.04 Million | -2.3 Million | 102 Thousand | 794.84 Thousand | -609.69 Thousand | -892.73 Thousand |
MOREPENLAB
GBLX
MOTILALOFS
PHVS
TI
LXCHEM